These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date and reported results 2005-003971-19 Clinical study to evaluate the ability of Muse to increase erectile function in post-radical prostatectomy patients. 2008-08-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001510-32 Active-Controlled Trial of the Safety and Tolerability of MP03-33 in Patients with Chronic Allergic or Nonallergic Rhinitis 2007-12-28 bad-data
Reported results 2007-002553-23 Clinical trial to assess the protective effect of the fixed drug combination of disodium cromoglycate plus reproterol in comparison to the single components and placebo in adults with exercise induced... 2008-10-30 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-004884-24 Long-term effects of Aldara® 5% cream and Solaraze® 3% gel in the treatment of actinic keratoses on the face or scalp (LEIDA) 2012-11-20 bad-data
Ongoing 2008-002501-39 Quality of life of patients with actinic keratoses and/or a superficial basal cell carcinoma treated with Imiquimod 5% cream. not-yet-due
Listed as ongoing, but also has a completion date and reported results 2009-012083-14 An Open-Label, Multicenter Study of the Effects of Remission Maintenance Therapy with Ceplene® (Histamine Dihydrochloride), Given in Conjunction with Low-Dose Interleukin-2 (IL-2, Proleukin®), on Immu... 2014-06-04 bad-data
Reported results 2009-014441-93 Clinical trial to assess the efficacy of the fixed combination product Tepilta® in the treatment of radiation-induced oesophagitis compared to its active ingredients oxetacaine and antacids, and to p... 2017-01-18 due-trials
Reported results 2010-022054-16 Long-term effects of Aldara® 5% cream and 2015-03-27 due-trials
Trial is outside EEC, and reported results 2011-001369-42 Randomized, Double-Blind Trial of MP29-02 Nasal Spray Compared to Placebo, Azelastine Hydrochloride Nasal Spray, and Fluticasone Propionate Nasal Spray in the Treatment of Patients with Seasonal Aller... bad-data
Trial is outside EEC, and reported results 2011-001370-26 Randomized, Double-Blind Trial of MP29-02 Nasal Spray Compared to Placebo, Azelastine Hydrochloride Nasal Spray, and Fluticasone Propionate Nasal Spray in the Treatment of Patients with Seasonal Aller... bad-data
Trial is outside EEC, and reported results 2011-001371-39 Randomized, Double-Blind Trial of MP29-02 Nasal Spray Compared to Placebo, Azelastine Hydrochloride Nasal Spray and Fluticasone Propionate Nasal Spray in the Treatment of Patients with Seasonal Allerg... bad-data
Ongoing 2014-001088-11 Academic study on the effects of MP 29-02 nasal spray on inflammatory mediators in allergic rhinitis not-yet-due